Description
In this episode of Clinical Lab Chat, Director of Business Intelligence Chris Wolski interviews Jeff Andrews, MD, FRCSC, a board-certified gynecologist and vice president of Global Medical Affairs for Diagnostic Solutions at BD, what HPV sample self-collection means for the diagnosis, prevention, and treatment of HPV and cervical cancer.
Among the topics they cover in this wide-ranging interview:
How HPV sample self-collection will improve testing and treatment access.The importance of sample integrity.The larger public health implications of making HPV and cervical cancer screening routine and accessible.The findings of a recent UN General Assembly meeting about HPV diagnosis and treatment.What it’s going to take to make cervical cancer a thing of the past.
In this edition of Clinical Lab Chat, Director of Business Intelligence Chris Wolski discusses with Courtney Noah, PhD, VP of Scientific Affairs at BioIVT, how blood-based biofluid testing is poised to revolutionize cancer diagnostics.
Among the topics they dig into are:
The benefits of...
Published 09/27/24
In this episode of Clinical Lab Chat, CLP’s director of business intelligence, Chris Wolski, discusses how point-of-care testing improves access to both diagnostics and treatment with Seth Egan, co-founder of and chief commercialization officer for Co-Diagnostics.
Among the topics they cover in...
Published 09/18/24